http://www.law360.com/ Latest articles for organization: McKesson Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/132620 A federal judge has ordered the California Department of Health Care Services to cough up documents after siding with McKesson Corp. in a discovery battle in a proposed class action accusing the company of conspiring to inflate the average wholesale price of hundreds of drugs. http://www.law360.com/articles/132620 http://www.law360.com/articles/127634 A California appeals court has vacated and remanded a lower court's decision to stay declaratory relief for Great American Insurance Co. in a liability insurance dispute with its policyholder Angeles Chemical Co. Inc. over chemical cleanup costs, saying Angeles had not proven that a decision on relief would overlap with a decision on the underlying suit between the two parties. http://www.law360.com/articles/127634 http://www.law360.com/articles/124783 A federal judge has dismissed a $2.3 billion antitrust lawsuit accusing 16 pharmaceutical manufacturers and a group of drug distributors of conspiring to keep a Long Island, N.Y.-based secondary wholesaler out of business. http://www.law360.com/articles/124783 http://www.law360.com/articles/124172 Less than a week after asking a court to dismiss Bristol-Myers Squibb Co. from a suit, the state of Arizona has revealed that the parties have reached a $900,000 settlement that will put to rest allegations that the pharmaceutical giant schemed to artificially boost average wholesale drug prices. http://www.law360.com/articles/124172 http://www.law360.com/articles/123214 A subsidiary of patent-holding company Acacia Research Corp. has resolved its suit against AGFA Healthcare Corp., ending the companies' patent spat over medical imaging technology. http://www.law360.com/articles/123214 http://www.law360.com/articles/122825 The state of Arizona has asked a court to dismiss Bristol-Myers Squibb Co. from multidistrict litigation accusing a number of pharmaceutical companies of scheming to artificially boost average wholesale drug prices, following a settlement agreement between the two parties. http://www.law360.com/articles/122825 http://www.law360.com/articles/120613 A federal appeals court has shot down an appeal by pharmacy industry groups arguing that recent settlements in average wholesale price litigation against drug pricing publishers First Databank Inc. and Medi-Span will cause independent pharmacies to go out of business. http://www.law360.com/articles/120613 http://www.law360.com/articles/103268 The standards applicable to merger cases in federal courts are in need of reform, and the FTC ought not to be able to shut down a merger without showing a likelihood of success at the administrative trial, says Richard Parker, head of the antitrust and competition practice group at O'Melveny & Myers LLP. http://www.law360.com/articles/103268 http://www.law360.com/articles/109450 San Francisco city officials have asked the federal court overseeing their suit accusing McKesson Corp. of conspiring to inflate the average wholesale price of hundreds of drugs to certify a class of all governmental entities in California, including the state itself, that overpaid for the drugs. http://www.law360.com/articles/109450 http://www.law360.com/articles/108756 Bingham McCutchen LLP is facing new calls that it be disqualified for allegedly stealing expert witnesses and violating multiple court orders in long-running and rancorous litigation involving the cleanup of a contaminated California bulk-chemical distribution facility, with opposing counsel calling Bingham's actions “appalling.” http://www.law360.com/articles/108756 http://www.law360.com/articles/102963 DR Systems Inc. has reached a settlement with eRAD Inc., leaving one defendant in a lawsuit filed against three medical technology companies for allegedly infringing a patent covering medical imaging systems. http://www.law360.com/articles/102963 http://www.law360.com/articles/99426 Representatives of the pharmacy industry are objecting to recent settlements in average wholesale price litigation against drug pricing publishers First DataBank Inc. and Medi-Span, claiming the deal will cost pharmacies $68 million a year in Medicaid reimbursements. http://www.law360.com/articles/99426 http://www.law360.com/articles/96868 Federal regulators have settled their case against a former executive of health care services provider McKesson Corp. accused of insider trading in connection with the company's purchase of D&K Healthcare Resources Inc. in 2005. http://www.law360.com/articles/96868 http://www.law360.com/articles/84041 An oversight body for the New York Stock Exchange referred a record number of suspected insider trading violation cases to the U.S. Securities and Exchange Commission in 2008. The number of those cases involving probable hedge funds, however, fell last year after steadily rising since 2002. http://www.law360.com/articles/84041 http://www.law360.com/articles/81803 The San Francisco Health Plan and Connecticut have asked a court to lift its stay on their lawsuits accusing McKesson Corp. of conspiring to inflate the average wholesale price of drugs, now that the drug distributor has settled a related private-party litigation. http://www.law360.com/articles/81803 http://www.law360.com/articles/77794 McKesson Corp. has agreed to pay $350 million to settle all private-party litigation alleging the pharmaceutical distributor conspired to raise the average wholesale price for thousands of drugs. http://www.law360.com/articles/77794 http://www.law360.com/articles/76862 A former executive at health care services provider McKesson Corp. has been accused of insider trading in connection with the company's purchase of D&K Healthcare Resources Inc. in 2005. http://www.law360.com/articles/76862 http://www.law360.com/articles/76768 A former executive at health care services provider McKesson Corp. has agreed to disgorge over $117,000 to settle insider trading charges stemming from his company's purchase of D&K Healthcare Resources Inc. http://www.law360.com/articles/76768 http://www.law360.com/articles/76164 The city of Baltimore has launched a class action on behalf of Maryland governmental entities accusing McKesson Corp. of scheming to raise and fix pharmaceutical drug prices, costing the plaintiffs millions of dollars in inflated reimbursements. http://www.law360.com/articles/76164 http://www.law360.com/articles/75448 Two former executives of health care software firm HBO & Co. may have to stand a second trial for securities fraud charges related to the company’s 1999 merger with pharmaceutical distributor McKesson Corp., following a recent appeals court ruling. http://www.law360.com/articles/75448